Broker Recommendations
Shire's haemophilia unit 'is sustainable', but Societe Generale trims target price
Analysts at Societe Generale took a look at biotech company Shire on Wednesday, both execution and communication need to improve for investors to ignore the "thousand cuts" and focus on the payday ahead as it cut its target price by 500p.
Asiamet the 'best kept secret in copper', says Liberum
Copper explorer Asiamet Resources was tipped as a 'buy' by Liberum on Wednesday as it has assets near to production and "globally significant" in scale, with its valuation implying it is the "best kept secret in copper".
Buy James Fisher shares while they are cheap, Canaccord says
Investors should take advantage of an unusual opportunity to buy James Fisher and Sons shares relatively cheaply, according to analysts at Canaccord Genuity.
Liberum downgrades Safestyle after profit warning
Liberum cut its stance on AIM-listed windows and doors specialist Safestyle to ‘hold’ from ‘buy’ after it warned on 2018 revenue and profits on Wednesday, reducing the target price to 130p from 200p.